Inspira Technologies Confirms Shareholder Approval After Adjourned December 30 Meeting

An update from Inspira Technologies Oxy BHN ( (IINN) ) is now available.

Inspira Technologies Oxy B.H.N. Ltd., an Israeli foreign private issuer listed in the United States, operates within the medical technology and healthcare sector, though this filing focuses on its corporate governance and regulatory compliance rather than its products or services.

On December 30, 2025, the company convened its Annual and Extraordinary General Meeting of Shareholders, which was initially adjourned at 4:00 p.m. Israel time due to lack of quorum but successfully reconvened and held at 6:00 p.m., when a quorum was present and shareholders approved the agenda item described in the previously distributed notice and proxy statement; the resulting Form 6-K has been incorporated by reference into several of Inspira Technologies’ existing U.S. securities registration statements, underscoring its ongoing compliance with SEC reporting and governance requirements.

The most recent analyst rating on (IINN) stock is a Hold with a $0.91 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.

The score is weighed down primarily by very weak financial performance (ongoing losses, negative gross profit, and significant cash burn with reliance on external funding). Technicals are also weak with negative momentum and trading below most key moving averages. Valuation provides little support because the negative P/E reflects unprofitable operations and there is no dividend yield.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Average Trading Volume: 197,899

Technical Sentiment Signal: Strong Sell

Current Market Cap: $33.93M

See more data about IINN stock on TipRanks’ Stock Analysis page.